PhD – Molecular Cancer Biology – Germany

The research group of Prof. Dimitrios Papadopoulos at the University of Würzburg investigates RNA-based mechanisms of tumor maintenance.

They are currently looking for an ambitious PhD candidate with an outstanding background in Biochemistry. The position is funded by the UbiQancer CRC/TRR 387 and University core funding. The project will be carried out in the vibrant Biocenter of the University of Würzburg.

The succesful candidate will characterize first-of-their-kind proteolysis targeting chimera (PROTAC) compounds in colorectal cancer cells.

Requirements

• Excellent MSc degree in biochemistry, or a related field.
• Wet-lab experience in one of these fields.
• Fluency in written/spoken English (minimum C1 level), knowledge of German is not required.
• Prior experience in compound screening assays, such as HiBiT is highly advantageous.

Benefits

• Cutting-edge, well-funded research projects.
• Training in state-of-the-art compound screening assays, including HiBiT and ternary complex formation assays.
• Training in the performance and bioinformatic analysis of modern sequencing techniques such as CLIP-seq and TT-seq.
• Appointment for a minimum of 3 years with a competitive salary (TV-L E13).
• Hands-on supervision with internal skill building seminars.
• Close collaboration with leading experts in medicinal chemistry, molecular and structural biology.
• Enrolment in the Graduate School of Life Science, which offers a wide range of skill building courses.
• Excellent networking opportunities within the University of Würzburg, the Mildred Scheel Early Career Center and the UbiQancer consortium.

Organisation/Company –UNI WUERZBURG.

Field of research – Biological sciences » Biology.

Research profile – First Stage Researcher (R1).

Country – Germany.

Application deadline – 15 Feb 2026 – 09:00 (Europe/Berlin).

More information: Euraxess